Figure 1. a, b.
Patient and physician assessment of FMF disease activity at baseline and after IL-1 blocking therapy (a); frequency of FMF attacks at baseline and after IL-1 blocking therapy (b)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.